钱晓华, 沈洪波, 黄慧嫦, 张莉, 孙俪燕. 健康老年人23价肺炎链球菌多糖疫苗接种效果分析[J]. 上海预防医学, 2020, 32(12): 1006-1011. DOI: 10.19428/j.cnki.sjpm.2020.20313
引用本文: 钱晓华, 沈洪波, 黄慧嫦, 张莉, 孙俪燕. 健康老年人23价肺炎链球菌多糖疫苗接种效果分析[J]. 上海预防医学, 2020, 32(12): 1006-1011. DOI: 10.19428/j.cnki.sjpm.2020.20313
QIAN Xiao-hua, SHEN Hong-bo, HUANG Hui-chang, ZHANG Li, SUN Li-yan. Immune response in healthy elderly after inoculation with PPV23[J]. Shanghai Journal of Preventive Medicine, 2020, 32(12): 1006-1011. DOI: 10.19428/j.cnki.sjpm.2020.20313
Citation: QIAN Xiao-hua, SHEN Hong-bo, HUANG Hui-chang, ZHANG Li, SUN Li-yan. Immune response in healthy elderly after inoculation with PPV23[J]. Shanghai Journal of Preventive Medicine, 2020, 32(12): 1006-1011. DOI: 10.19428/j.cnki.sjpm.2020.20313

健康老年人23价肺炎链球菌多糖疫苗接种效果分析

Immune response in healthy elderly after inoculation with PPV23

  • 摘要:
    目的了解健康老年人接种23价肺炎链球菌多糖疫苗(PPV23)后功能性抗体水平和对社区获得性肺炎(CAP)的保护效果。
    方法2015年在上海市虹口区内选择≥60岁健康老年人48人,在其PPV23接种前、接种后1个月和6个月时分别采集血标本,采用肺炎链球菌荚膜多糖特异性抗体多型调理吞噬试验(MOPA)检测13种血清型(1、3、4、5、6A、6B、7F、9V、14、18C、19A、19F、23F)肺炎链球菌的OPA抗体;同时调查其接种PPV23后的CAP发病情况。
    结果健康老年人接种PPV23后1个月、6个月时13种血清型OPA抗体GMT均显著高于接种前。接种PPV23后1个月各血清型OPA抗体≥2倍增长率、≥4倍增长率分别为64.58%~87.00%、43.75%~75.00%;接种PPV23后6个月各血清型OPA抗体≥2倍增长率、≥4倍增长率分别为45.71%~82.86%、40.00%~80.00%;接种后6个月与接种后1个月的OPA抗体增长率相比,大多数血清型的差异均无统计学意义。自身前后描述性研究显示,健康老年人接种PPV23后第1、2年对CAP的保护效果分别为100.00%、50.00%。
    结论PPV23接种健康老年人后具有较好的免疫原性和免疫持久性,对CAP具有较好的保护效果。

     

    Abstract:
    ObjectiveTo analyze functional antibody and protection effect against pneumonia after inoculation with 23-valent pneumococcal polysaccharide vaccine(PPV23)in healthy elderly.
    MethodsIn 2015, 48 healthy elderly people aged ≥60 years were randomly selected in Hongkou District of Shanghai, and their blood samples were collected before, and 1 month and 6 months after the inoculation of PPV23.Functional antibodies against 13 serotypes(1、3、4、5、6A、6B、7F、9V、14、18C、19A、19F、23F)of streptococcus pneumonia were determined by muti-specificity opsonophagocyitosis killing assay(MOPA).The incidence of community-acquired pneumonia(CAP)after PPV23 inoculation was also investigated.
    ResultsThe GMT of OPA antibodies against 13 serotypes were higher 1 and 6 months after inoculation than that before inoculation.One month after the inoculation, OPA antibodies against 13 serotypes ≥2 times growth rate and ≥4 times growth rate were 64.58%-87.00% and 43.75%-75.00%, respectively.Six months after inoculation with PPV23, OPA antibodies against 13 serotypes ≥2 times growth rate and ≥4 times growth rate were 45.71%-82.86%, 40.00%-80.00%, respectively.There was no significant difference in the growth rate of OPA antibody between 6 months and 1 month after vaccination for most serotypes.Results of self-descriptive survey before and after the inoculation showed that the protection against CAP in healthy elderly people in the first and second years after PPV23 inoculation was 100.00% and 50.00%, respectively.
    ConclusionPPV23 has better immunogenicity and immune persistence after inoculation in healthy elderly people, and has better protective effect against CAP.

     

/

返回文章
返回